Pfizer Chantix (Varenicline) Tablet Recall [US]

Click to enlarge image

US/Silver Spring: Pfizer, a Manhattan, New York establishment, recalls certain batch/lots of Chantix Tablets due to the presence of N-nitroso-varenicline contamination and consequential risks of increased carcinogenicity (Cancer), severe illness and/or possible life-changing complications, all serious health and safety hazards/situations requiring immediate medical intervention to minimize suffering and prevent life-changing injury.

FDA: http://ht.ly/sDqw30rRBS6

Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/pfizer-expands-voluntary-nationwide-recall-include-four-additional-lots-chantixr-varenicline-tablets

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Chantix (Varenicline) Tablets are subject to this recall:

Lupin Pharma Metformin Hydrochloride Tablet Recall [US]

Click to enlarge image

US/Silver Spring: Lupin Pharmaceuticals, Inc., a Baltimore, Maryland establishment, recalls all current batch/lots of Lupin Pharma branded Metformin Hydrochloride Extended Release Tablets from the American marketplace due to suspected N-Nitrosodimethylamine (“NDMA”) contamination in amounts above acceptable FDA levels with consequential risks of Cancer, severe illness and/or possible life-changing complications, all serious health hazards.

FDA: http://ht.ly/NuJP30qY97Z

Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/lupin-pharmaceuticals-inc-issues-voluntarily-nationwide-recall-metformin-hydrochloride-extended

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Metformin medications are subject to this recall:

Granules Pharma Metformin Hydrochloride Recall [US]

Click to enlarge image

US/Silver Spring: Granules Pharmaceuticals, Inc., a Chantilly, Virginia establishment, recalls twelve (12) batch/lots of Metformin Hydrochloride Extended-Release Tablets USP, 750 mg from the American marketplace due to suspected N-Nitrosodimethylamine (“NDMA”) contamination in amounts above acceptable FDA levels with consequential risks of Cancer, severe illness and/or possible life-changing complications, all serious health hazards.

FDA: http://ht.ly/dXLm30qX5hG

Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/granules-pharmaceuticals-inc-issues-voluntary-nationwide-recall-metformin-hydrochloride-extended

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Metformin medications are subject to this recall:

Apotex Metformin Hydrochloride Tablet Recall [Canada]

Click to enlarge image

Canada/Ottawa: Apotex Corp., a Toronto, Ontario establishment, recalls certain batch/lots of Apotex Corp branded Metformin Hydrochloride Extended-Release Tablets from the American marketplace due to suspected N-Nitrosodimethylamine (“NDMA”) contamination in amounts above acceptable Health Canada levels with consequential risks of Cancer, severe illness and/or possible life-changing complications, all serious health hazards.

HCSC: http://ht.ly/RIm630qRn75

Direct link: https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2020/73339r-eng.php

Additional information:
The Health Canada (“HCSC) reports the following Metformin medications are subject to this recall:

Lupin Pharma Metformin Hydrochloride Tablet Recall [US]

Click to enlarge image

US/Silver Spring: Lupin Pharmaceuticals, Inc., a Baltimore, Maryland establishment, recalls certain batch/lots of Lupin Pharma branded Metformin Hydrochloride Extended Release Tablets from the American marketplace due to suspected N-Nitrosodimethylamine (“NDMA”) contamination in amounts above acceptable FDA levels with consequential risks of Cancer, severe illness and/or possible life-changing complications, all serious health hazards.

FDA: http://ht.ly/GfnZ30qQfdN

Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/lupin-pharmaceuticals-inc-issues-voluntarily-nationwide-recall-one-lot-metformin-hydrochloride

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Metformin medications are subject to this recall:

Apotex Metformin Hydrochloride Tablet Recall [US]

Click to enlarge image

US/Silver Spring: Apotex Corp., a Toronto, Ontario establishment, recalls certain batch/lots of Apotex Corp branded Metformin Hydrochloride Extended-Release Tablets from the American marketplace due to suspected N-Nitrosodimethylamine (“NDMA”) contamination in amounts above acceptable FDA levels with consequential risks of Cancer, severe illness and/or possible life-changing complications, all serious health hazards.

FDA: http://ht.ly/HmUE30qPhSK

Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/apotex-corp-issues-voluntary-nationwide-recall-metformin-hydrochloride-extended-release-tablets

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Metformin medications are subject to this recall:

Actavis Pharma Metformin Hydrochloride Tablet Recall [US]

Click to enlarge image

US/Silver Spring: Teva Pharmaceuticals USA, Inc., a Parsippany, New Jersey establishment and subsidiary of Teva Pharmaceutical Industries Ltd. of Petah Tikva, Israel, recalls certain batch/lots of Actavis Pharma, Inc. branded Metformin Hydrochloride Extended Release Tablets from the American marketplace due to suspected N-Nitrosodimethylamine (“NDMA”) contamination in amounts above acceptable FDA levels with consequential risks of Cancer, severe illness and/or possible life-changing complications, all serious health hazards.

FDA: http://ht.ly/q9Pu30qOed1

Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/teva-pharmaceuticals-usa-inc-initiates-voluntary-nationwide-recall-metformin-hydrochloride-extended

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Metformin medications are subject to this recall:

Time-Cap Labs Metformin Hydrochloride Tablet Recall [US]

Click to enlarge image

US/Silver Spring: Marksans Pharma Limited, a Verna, Goa, India establishment, recalls certain batch/lots of Time-Cap Labs, Inc. branded Metformin Hydrochloride Extended Release Tablets from the American marketplace due to suspected N-Nitrosodimethylamine (“NDMA”) contamination in amounts above acceptable FDA levels with consequential risks of Cancer, severe illness and/or possible life-changing complications, all serious health hazards.

FDA: http://ht.ly/upL630qNRGM

Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/marksans-pharma-limited-issues-voluntary-nationwide-recall-metformin-hydrochloride-extended-release

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Metformin medications are subject to this recall:

Amneal Metformin Hydrochloride Tablet Recall [US]

Click to enlarge image

US/Silver Spring: Amneal Pharmaceuticals LLC, a Bridgewater, New Jersey establishment, recalls all current batch/lots of Metformin Hydrochloride Extended Release Tablets from the American marketplace due to suspected N-Nitrosodimethylamine (“NDMA”) contamination in amounts above acceptable FDA levels with consequential risks of Cancer, severe illness and/or possible life-changing complications, all serious health hazards.

FDA: http://ht.ly/pU8030qNxkW

Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/amneal-pharmaceuticals-llc-issues-voluntary-nationwide-recall-metformin-hydrochloride-extended

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Metformin medications are subject to this recall:

American Health Ranitidine Tablet Recall [US]

Click to enlarge

US/Silver Spring: American Health Packaging, a Columbus, Ohio establishment, recalls eleven (11) lots of Ranitidine Tablets, USP 150 mg, 100 count Unit Dose Blisters from the American marketplace due to suspected levels of N-Nitrosodimethylamine (“NDMA”), a probable Human Carcinogen, above the allowable limits established by the FDA and consequential risk of Cancer, all serious health hazards.

FDA: http://ht.ly/gFcQ30qnOVO

Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/american-health-packaging-issues-voluntary-nationwide-recall-ranitidine-tablets-usp-150-mg-100-count

Additional information:
The US Food and Drug Administration (“FDA”) reports the following prescription drug products are subject to this recall:

Torrent Pharma Losartan Recall [US]

US/Silver Spring: Torrent Pharmaceuticals Limited, an Ahmedabad, Gujarat establishment, expands its existing recalls from two (2) lots of Losartan Potassium Tablets USP to a total of ten (10) lots all unexpired batch/lots of due to suspected N-Nitrosodimethylamine (“NDMA”) contamination and consequential risks of Carcinogen damage and Cancer, all serious health hazards.

FDA: http://ht.ly/RmeV30ndMED

Direct link: https://www.fda.gov/Safety/Recalls/ucm629261.htm

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Losartan Tablets are subject to this recall:

Torrent Pharma Valsartan Recall [US]

US/Silver Spring: Torrent Pharmaceuticals Limited, an Ahmedabad, Gujarat establishment, recalls all unexpired batch/lots of Valsartan/Amlodipine/HCTZ, Valsartan/Amlodipine and Valsartan Tablets due to suspected N-Nitrosodimethylamine (“NDMA”) contamination and consequential risks of Carcinogen damage and Cancer, all serious health hazards.

FDA: http://ht.ly/Qhee30lylJS

Direct link: https://www.fda.gov/Safety/Recalls/ucm617821.htm

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Valsartan Tablets are subject to this recall:

Camber Pharma Valsartan Recall [US]

US/Silver Spring: Camber Pharmaceuticals, Inc., a Piscataway, New Jersey, establishment, recalls all all unexpired batch/lots of Valsartan Tablets due to suspected N-Nitrosodimethylamine (“NDMA”) contamination and consequential risks of Carcinogen damage and Cancer, all serious health hazards.

FDA: http://ht.ly/klmd30ln4Uq

Direct link: https://www.fda.gov/Safety/Recalls/ucm616405.htm

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Valsartan Tablets are subject to this recall: